Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues

Advances over the past decade in the management of multiple sclerosis (MS) have led to improved patient outcomes and renewed optimism among patients and clinicians alike. However, in the United States, the growing complexity of MS care has been paralleled by an increasingly regulated health care system and restraints imposed by third-party payors. To continue to maintain viable practices and offer patients optimal care, clinicians need to develop and refine investigations and therapeutic regimens that are appropriate for use in patients with MS while satisfying the fiscal concerns of third-party payors.